NCT07551193Active, not recruiting
Evaluating Weight Loss Outcomes in Patients With Overweight or Obesity
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
The goal of this observational study is to evaluate weight loss outcomes in adults with overweight or obesity using weight management medications. The main questions it aims to answer are: (1) How much weight do patients lose after 12 months? (2) Do blood sugar and cholesterol levels improve? (3) How safe and tolerable are these medications? This is a retrospective study using existing medical records and pharmacy claims. Participants will not be asked to do anything new; all data will be collected from routine clinical care.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 20 Apr 2026
- Start date
- 25 Oct 2025
- Primary completion date
- 25 Jun 2026
- Lead sponsor
- Aldafter Medical Center, Bahrain
- Diseases
- Obesity
- NCT number
- NCT07551193
What you commit to
- Study type: Observational
- Planned participants: 300
- From 25 Oct 2025 to the primary completion date, 25 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Non-Compliance: Evidence of non-compliance with treatment (e.g., gaps in therapy greater than 30 days).
- Bariatric Surgery: Patients who have undergone bariatric surgery in the past 5 years.
Other illness
- Type 1 Diabetes: Patients with a diagnosis of type 1 diabetes.
- Serious Comorbidities: Presence of serious medical conditions that may confound weight loss outcomes (e.g., uncontrolled psychiatric disorders, cancer).
Who the study is looking for
- Age: Adults aged 18 years or older.
- Body Mass Index (BMI): Patients classified as overweight (BMI 25-29.9 kg/m²) or obese (BMI ≥30 kg/m²).
- Medication: At least one pharmacy claim for any approved weight management medication
- Continuous Enrollment: Patients must have continuous enrollment in medical and pharmacy insurance for 1 year prior to the index date (date of treatment initiation) and 1 year afterward.
- \-
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AlDafter Medical center Coordinator of this site? Confirm its status | Manama | Bahrain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.